Meloxicam injection - Heron Therapeutics
Alternative Names: APF 328; APF 505Latest Information Update: 02 Oct 2021
At a glance
- Originator A.P. Pharma
- Developer Heron Therapeutics
- Class 2 ring heterocyclic compounds; Amides; Analgesics; Anti-inflammatories; Antipyretics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Small molecules; Thiazines; Thiazoles
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Suspended Osteoarthritis; Postoperative inflammation
Most Recent Events
- 13 Jan 2014 A.P. Pharma is now called Heron Therapeutics
- 12 Dec 2006 Pre-IND development is still ongoing
- 04 Aug 2005 This product is still in active development